Приказ основних података о документу

dc.creatorEnck, Paul
dc.creatorAziz, Qasim
dc.creatorBarbara, Giovanni
dc.creatorFarmer, Adam D.
dc.creatorFukudo, Shin
dc.creatorMayer, Emeran A.
dc.creatorNiesler, Beate
dc.creatorQuigley, Eamonn M. M.
dc.creatorRajilić-Stojanović, Mirjana
dc.creatorSchemann, Michael
dc.creatorSchwille-Kiuntke, Juliane
dc.creatorSimren, Magnus
dc.creatorZipfel, Stephan
dc.creatorSpiller, Robin C.
dc.date.accessioned2021-03-10T13:00:54Z
dc.date.available2021-03-10T13:00:54Z
dc.date.issued2016
dc.identifier.issn2056-676X
dc.identifier.urihttp://TechnoRep.tmf.bg.ac.rs/handle/123456789/3234
dc.description.abstractIrritable bowel syndrome (IBS) is a functional gastrointestinal disease with a high population prevalence. The disorder can be debilitating in some patients, whereas others may have mild or moderate symptoms. The most important single risk factors are female sex, younger age and preceding gastrointestinal infections. Clinical symptoms of IBS include abdominal pain or discomfort, stool irregularities and bloating, as well as other somatic, visceral and psychiatric comorbidities. Currently, the diagnosis of IBS is based on symptoms and the exclusion of other organic diseases, and therapy includes drug treatment of the predominant symptoms, nutrition and psychotherapy. Although the underlying pathogenesis is far from understood, aetiological factors include increased epithelial hyperpermeability, dysbiosis, inflammation, visceral hypersensitivity, epigenetics and genetics, and altered brain-gut interactions. IBS considerably affects quality of life and imposes a profound burden on patients, physicians and the health-care system. The past decade has seen remarkable progress in our understanding of functional bowel disorders such as IBS that will be summarized in this Primer.en
dc.publisherNature Research, Berlin
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/607652/EU//
dc.relationinternational network COST Action BM1106 GENIEUR (GENes in Irritable Bowel Syndrome Research Network EURope)
dc.relationNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK048351, R01DK048351,
dc.rightsopenAccess
dc.sourceNature Reviews Disease Primers
dc.titleIrritable bowel syndromeen
dc.typearticle
dc.rights.licenseARR
dc.citation.other2: -
dc.citation.rankaM21
dc.citation.volume2
dc.identifier.doi10.1038/nrdp.2016.14
dc.identifier.fulltexthttp://TechnoRep.tmf.bg.ac.rs/bitstream/id/9419/nrdp201614.pdf
dc.identifier.pmid27159638
dc.identifier.scopus2-s2.0-85006778902
dc.identifier.wos000381361800001
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу